Public consultation before approval of Type 1 use of a genetically modified live vaccine for dogs
遺伝子組換え生ワクチン（犬用）の第一種使用等に関する承認に先立っての意見募集について
Published: 2026-10-27 · Source: e-Gov Public Comment · Stage: Public Comment Open · Area: Other · Impact (preliminary): Medium · Comment deadline: 2026-11-26 00:00 JST · First detected by this dashboard: 2026-10-27
View the original Japanese source Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
A public consultation concerning approval of Type 1 use and related activities for a genetically modified live vaccine for dogs was announced on 2026-10-27; the stated comment deadline is 2026-11-26 00:00 JST. The listed responsible office is the Office for Alien Species Management, Wildlife Division, Nature Conservation Bureau, Ministry of the Environment.
Business Impact
The proposed approval may be relevant to suppliers and users of the genetically modified live vaccine for dogs because it concerns its Type 1 use and related activities; the specific vaccine and proposed conditions are not identified in the supplied information.
Recommended Action
Reviewing the official Japanese consultation documents would help clarify the vaccine concerned, the scope of Type 1 use and related activities, and any proposed approval conditions.